Showing 1811-1820 of 3314 results for "".
- CooperVision Launches ‘Made Better Promise’ to Advance Sustainability in Contact Lenseshttps://modernod.com/news/coopervision-launches-made-better-promise-to-advance-sustainability-in-contact-lenses/2486576/Key Takeaways CooperVision launched the Made Better Promise, a global sustainability platform embedded across the lifecycle of its contact lens products, starting with MyDay.
- IDOC Launches Easyvision Private Label Contact Lens Portfolio for Independent Optometristshttps://modernod.com/news/idoc-launches-easyvision-private-label-contact-lens-portfolio-for-independent-optometrists/2486489/Key Takeaways easyvision is a new private label daily disposable contact lens portfolio from IDOC, manufactured by CooperVision
- Study Finds GLP-1 Drugs Linked to Lower Risk of Legal Blindness in Type 2 Diabeteshttps://modernod.com/news/study-finds-glp-1-drugs-linked-to-lower-risk-of-legal-blindness-in-type-2-diabetes/2486332/A large real-world study suggests that widely used GLP-1 receptor agonists—commonly prescribed for type 2 diabetes and weight management—may significantly reduce the risk of legal blindness in high-risk patients. The research,
- FDA Issues Third Complete Response Letter to Aldeyra Therapeutics for Dry Eye Drug Reproxalaphttps://modernod.com/news/fda-issues-third-complete-response-letter-to-aldeyra-therapeutics-for-dry-eye-drug-reproxalap/2486097/In another setback for Aldeyra Therapeutics, the FDA issued a third Complete Response Letter (CRL) regarding its new drug application (NDA) for investigational dry eye treatment reproxalap. In the letter, the FDA stated that th
- New Research Highlights Opticians’ Key Role in Contact Lens Success, Strong Patient Trusthttps://modernod.com/news/new-research-highlights-opticians-key-role-in-contact-lens-success-strong-patient-trust/2486039/Key Takeaways 89% of contact lens wearers say
- BostonSight Announces Leadership Changes to Advance Ocular Surface Care Worldwidehttps://modernod.com/news/bostonsight-announces-leadership-changes-to-advance-ocular-surface-care-worldwide/2485722/BostonSight announced a 5-year strategic roadmap designed to redefine ocular surface treatment through advancements in clinical research, professional education, and specialty lens technology. As part of the plan, BostonSight announced a new leadership structure ai
- HOYA Presents New Data on MiYOSMART iQ Spectacle Lenseshttps://modernod.com/news/hoya-presents-new-data-on-miyosmart-iq-spectacle-lenses/2485625/HOYA Vision Care recently announced interim 6-month data from its randomized controlled clinical trial evaluating the safety and efficacy of MiYOSMART iQ spectacle lenses to treat children 4 to 12 years of age who have progressive myopia. The company’s myopia control solution uses the defocu
- Global Study Examines Orthokeratology Lenses and Childhood Myopia Progressionhttps://modernod.com/news/global-study-examines-orthokeratology-lenses-and-childhood-myopia-progression/2485610/A new international meta-analysis has found that orthokeratology lenses can significantly slow the progression of myopia in children, offering further evidence that the approach may play an important role in addressing the growing global myopia epidemic.
- Alcon Launches PRECISION7 Weekly Contact Lenses in Canadahttps://modernod.com/news/alcon-launches-precision7-weekly-contact-lenses-in-canada/2485580/Key Takeaways PRECISION7 is the only 1-week replacement contact lens with the ACTIV-FLO System, deliverin
- Contact Lens Institute Names 17 Eye Care Leaders as 2026 Visionarieshttps://modernod.com/news/contact-lens-institute-names-17-eye-care-leaders-as-2026-visionaries/2485504/Key Takeaways Contact Lens Institute named 17 U.S. and Canadian eye care professionals as 2026 Visionaries